{"id":"https://genegraph.clinicalgenome.org/r/64b7e717-3d73-47aa-a01d-e137bb17342fv1.1","type":"EvidenceStrengthAssertion","dc:description":"The *BBS7* gene was first reported in relation to Bardet-Biedl syndrome in a 2003 report of an affected individual from a consanguineous family (PMID: 12567324). Subsequent publications have established that cases diagnosed with Bardet-Biedl syndrome 7 exhibit retinal disease as the most penetrant feature, characterized by retinal dystrophy, often in a cone-rod pattern, photoreceptor layer loss, pigmentary retinopathy, reduced visual acuity, and/or retinal arteriolar constriction. These phenotypes are generally accompanied by diverse extraocular features such as obesity, polydactyly, renal abnormalities including cysts, abnormal morphology of the heart and/or liver, dental abnormalities such as crowding, hypoplastic external genitalia in males, and/or intellectual disability. Per criteria outlined by the ClinGen Lumping & Splitting Working Group, the mode of inheritance (autosomal recessive) and molecular mechanism (biallelic *BBS7* loss of function) were found to be consistent among patients diagnosed with Bardet-Biedl syndrome 7 (MIM# 615984), while the phenotypic variability between cases appears to represent a spectrum of disease rather than separate disease entities. Therefore, cases caused by inherited biallelic *BBS7* variants have been lumped into a single disease entity, referred to as BBS7-related ciliopathy.\n\nNine suspected disease-causing variants have been scored as part of this curation (two nonsense, five frameshift, one affecting splicing, and one missense), which have been collectively reported in seven probands in seven publications (PMID: 12567324, PMID: 19402160, PMID: 24849935, PMID: 25553308, PMID: 26557828, PMID: 26518167, PMID: 30839500). All of the probands scored in this curation harbored biallelic *BBS7* variants. The mechanism of pathogenicity appears to be biallelic loss of BBS7 function conferred by null and/or hypomorphic variants. Only two relatively small families were found in the literature (PMID: 12567324, PMID: 30839500), and segregation evidence did not contribute to the scoring of this curation.\n\nThis gene-disease association is also supported by biochemical evidence that *BBS7* encodes a component of the BBSome, a protein complex that functions in ciliogenesis and intraflagellar transport (PMID: 17574030). Consistent with these functions, BBS7 protein localizes to transition zones and ciliary axonemes and dynamically moves in both anterograde and retrograde directions along the ciliary axoneme (PMID: 15231740). BBS7 co-immunoprecipitates with BBS4 (PMID: 17574030), and the genes encoding other BBSome components have similarly been asserted in connection with various monogenic forms of Bardet-Biedl syndrome, including *BBS1* (PMID: 12118255), *BBS2* (PMID: 11285252), *ARL6* (PMID: 15258860), *BBS4* (PMID: 11381270), *BBS5* (PMID: 15137946), *MKKS* (PMID: 10973238, PMID: 10973251), and *TTC8* (PMID: 14520415). *C. elegans* with biallelic *Bbs-7* disruption exhibit short cilia and defects in cilia-based chemotaxis and intraflagellar transport (PMID: 15231740), while *bbs7* knockdown in zebrafish disrupts the ciliated organ controlling left-right patterning and triggers a defect in intracellular retrograde transport of melanosomes (PMID: 16399798). Biallelic disruption of *BBS7* orthologs in mice or macaques recapitulates many of the features of human patients, including retinal degeneration, abnormal renal morphology, and male reproductive defects (PMID: 23572516, PMID: 31589838).\n\nIn summary, *BBS7* is definitively associated with BBS7-related ciliopathy. This has been repeatedly demonstrated in both research and diagnostic settings, and has been upheld over time without the emergence of contradictory evidence, leading to a Definitive classification. This classification was approved by the ClinGen Retina Gene Curation Expert Panel on September 7th, 2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/64b7e717-3d73-47aa-a01d-e137bb17342f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a09e1836-927c-424d-b10c-fd93f3e6dc6b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a09e1836-927c-424d-b10c-fd93f3e6dc6b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2025-01-04T02:03:51.082Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/a09e1836-927c-424d-b10c-fd93f3e6dc6b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2023-09-07T16:00:00.000Z","role":"Approver"}],"curationReasons":["DiseaseNameUpdate"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a09e1836-927c-424d-b10c-fd93f3e6dc6b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9886972-7333-4249-b549-97746f48ab2d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9886972-7333-4249-b549-97746f48ab2d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26518167","rdfs:label":"Solmaz_2015_Proband_9","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":{"id":"https://genegraph.clinicalgenome.org/r/71f581a8-40f2-4ffc-829e-327da6950f1e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_176824.3(BBS7):c.712_715del (p.Arg238GlufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3064432"}},"detectionMethod":"Genotyping consisted of an NGS-based panel focusing on the BBS1, BBS2, ARL6, BBS4, BBS5, MKKS, BBS7, TTC8, BBS9, BBS10, TRIM32, BBS12, MKS1, CEP290, WDPCP, SDCCAG8, NPHP1 loci, followed by Sanger sequencing of the BBS7 locus.","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"The patient has been diagnosed with Bardet-Biedl syndrome.","phenotypes":["obo:HP_0000218","obo:HP_0001256","obo:HP_0000026","obo:HP_0000750","obo:HP_0010442","obo:HP_0001159","obo:HP_0000678","obo:HP_0000510","obo:HP_0031418","obo:HP_0001156"],"previousTesting":true,"previousTestingDescription":"Previous genotyping consisted of an NGS-based panel focusing on the BBS1, BBS2, ARL6, BBS4, BBS5, MKKS, BBS7, TTC8, BBS9, BBS10, TRIM32, BBS12, MKS1, CEP290, WDPCP, SDCCAG8, NPHP1 loci.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/614b35c6-9f17-4e80-867b-39aaf47172e0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26518167","allele":{"id":"https://genegraph.clinicalgenome.org/r/71f581a8-40f2-4ffc-829e-327da6950f1e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/614b35c6-9f17-4e80-867b-39aaf47172e0","type":"EvidenceLine","dc:description":"NM_018190.4:c.712_715del (p.Arg238GlufsTer59) is an out-of-frame deletion variant in exon 7 of 18 and is predicted to trigger nonsense-mediated decay or to at least truncate the C-terminal 65% of the protein product. Down-scoring has been performed for assumed consanguinity (present in many of the probands from this cohort) and the homozygous state of the variant.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/614b35c6-9f17-4e80-867b-39aaf47172e0_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/00965fe0-7777-47b7-bcb3-8a316796731a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00965fe0-7777-47b7-bcb3-8a316796731a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26557828","rdfs:label":"Suspitsin_2015_Proband_II.4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/953b46c5-32b6-4100-a02b-82d3b8fcecc2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_176824.3(BBS7):c.1967_1968delinsC (p.Leu656ProfsTer18)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA273047"}},"detectionMethod":"Previous genotyping consisted of exome sequencing, focused on the BBS1-BBS19 loci.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"The patient has been diagnosed with Bardet-Biedl syndrome and retinitis pigmentosa.","phenotypes":["obo:HP_0001256","obo:HP_0000054","obo:HP_0005280","obo:HP_0000510","obo:HP_0012743","obo:HP_0100259","obo:HP_0004324","obo:HP_0011220","obo:HP_5200120"],"previousTesting":true,"previousTestingDescription":"Genotyping consisted of exome sequencing, focused on the BBS1-BBS19 loci.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f8ad681c-4f71-4fe2-8396-d49235f84791_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26557828","allele":{"id":"https://genegraph.clinicalgenome.org/r/953b46c5-32b6-4100-a02b-82d3b8fcecc2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/f8ad681c-4f71-4fe2-8396-d49235f84791","type":"EvidenceLine","dc:description":"NM_176824.3(BBS7):c.1967_1968delinsC (p.Leu656fs) is an out-of-frame indel in exon 18 of 18 and is not predicted to trigger nonsense-mediated decay but rather to truncate the C-terminal 8% of the protein product. The homozygous state of the variant has been taken into account in the scoring.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8ad681c-4f71-4fe2-8396-d49235f84791_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/e7f71c39-016a-403f-b039-749d24dfe777_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7f71c39-016a-403f-b039-749d24dfe777","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19402160","rdfs:label":"Bin_2009_Family_04-01_Case_26","ageType":"AgeAtReport","ageUnit":"Years","ageValue":11,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/71f581a8-40f2-4ffc-829e-327da6950f1e"},{"id":"https://genegraph.clinicalgenome.org/r/d41eb311-f4b2-4fe2-b9ec-8e22f147bd18","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_176824.3(BBS7):c.1121C>G (p.Ser374Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358062298"}}],"detectionMethod":"Genotyping consisted of Sanger sequencing of the TTC8 and BBS7 loci.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"The patient has been diagnosed with Bardet-Biedl syndrome.","phenotypes":["obo:HP_0000548","obo:HP_0003077","obo:HP_0010442","obo:HP_0001513","obo:HP_0030515","obo:HP_0410042","obo:HP_0100543","obo:HP_0000077","obo:HP_0001133","obo:HP_0034685","obo:HP_0012758"],"previousTesting":true,"previousTestingDescription":"Previous genotyping consisted of Sanger sequencing of the TTC8 locus.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a05f4ef2-f9fb-44bf-91b3-bff83c2183e0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19402160","allele":{"id":"https://genegraph.clinicalgenome.org/r/71f581a8-40f2-4ffc-829e-327da6950f1e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/936c0017-a2dd-433f-b07e-9bd4d7a1d47e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19402160","allele":{"id":"https://genegraph.clinicalgenome.org/r/d41eb311-f4b2-4fe2-b9ec-8e22f147bd18"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/936c0017-a2dd-433f-b07e-9bd4d7a1d47e","type":"EvidenceLine","dc:description":"NM_176824.3:c.1121C>G (Ser374Ter) is a nonsense variant in exon 11 of 18 that is predicted to trigger nonsense-mediated decay or at least truncation of the C-terminal 48% of the protein product. Down-scoring has been performed due to the limitations of the genotyping method.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/936c0017-a2dd-433f-b07e-9bd4d7a1d47e_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a05f4ef2-f9fb-44bf-91b3-bff83c2183e0","type":"EvidenceLine","dc:description":"NM_176824.3:c.712_715del (p.Arg238GlufsTer?)is a frameshift variant in exon 7 of 18 that is predicted to trigger nonsense-mediated decay or at least truncation of the C-terminal 67% of the protein product. Down-scoring has been performed due to the limitations of the genotyping method. This variant has previously been scored in a separate proband.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a05f4ef2-f9fb-44bf-91b3-bff83c2183e0_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/00de2a0a-17e7-4c09-b208-5ee534ea215b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00de2a0a-17e7-4c09-b208-5ee534ea215b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24849935","rdfs:label":"Fattahi_2014_Patient_40302","allele":[{"id":"https://genegraph.clinicalgenome.org/r/0cb9a765-21bf-4ab7-b14f-b97a0e21df51","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_176824.3(BBS7):c.1342_1346del (p.Gln448ArgfsTer13)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580617740"}},{"id":"https://genegraph.clinicalgenome.org/r/bf6818cf-2e2f-4ef9-8b2b-1f1a402f6ac9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_176824.3(BBS7):c.1443T>A (p.Cys481Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358058685"}}],"detectionMethod":"Genotyping was performed using Sanger sequencing of the BSB1, BBS2, BBS10, BBS3, BBS4, BBS6, BBS7, BBS9, and BBS12 genes.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"The patient has been diagnosed with Bardet-Biedl syndrome and retinitis pigmentosa.","phenotypes":["obo:HP_0000639","obo:HP_0001627","obo:HP_0000077","obo:HP_0000545","obo:HP_0000510","obo:HP_0001513","obo:HP_0001829","obo:HP_0001161","obo:HP_0000026","obo:HP_0000708","obo:HP_0002463","obo:HP_0001156","obo:HP_0001511","obo:HP_0002251"],"previousTesting":true,"previousTestingDescription":"Previous genotyping consisted of Sanger sequencing of the BBS1, BBS2, BBS10, BBS3, BBS4, BBS6, BBS9, and BBS12 genes.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/066bbe48-3b82-4036-bdec-31ab7e677768_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24849935","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf6818cf-2e2f-4ef9-8b2b-1f1a402f6ac9"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/8b262d10-6630-4e6a-b7f7-4f05da24d24d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24849935","allele":{"id":"https://genegraph.clinicalgenome.org/r/0cb9a765-21bf-4ab7-b14f-b97a0e21df51"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/8b262d10-6630-4e6a-b7f7-4f05da24d24d","type":"EvidenceLine","dc:description":"NM_018190.4:c.1342_1346del (p.Gln448Argfs*13) is a frameshift variant in exon 13 of 18 that is predicted to trigger nonsense-mediated decay or to at least truncate the C-terminal 37% of the protein product.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b262d10-6630-4e6a-b7f7-4f05da24d24d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/066bbe48-3b82-4036-bdec-31ab7e677768","type":"EvidenceLine","dc:description":"NM_018190.4:c.1443T>A (p.Cys481Ter) is a nonsense variant in exon 14 of 18 that is predicted to trigger nonsense-mediated decay or to at least truncate the C-terminal 33% of the protein product.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/066bbe48-3b82-4036-bdec-31ab7e677768_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a09e1836-927c-424d-b10c-fd93f3e6dc6b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2aa2405-0b75-44a8-8c7a-349ced42956c_proband_segregation","type":"FamilyCosegregation","dc:description":"The pedigree meets the minimum requirement for 3 affected individuals.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30839500","rdfs:label":"Shen_2019_Family_1","estimatedLodScore":1.83,"family":{"id":"https://genegraph.clinicalgenome.org/r/b2aa2405-0b75-44a8-8c7a-349ced42956c","type":"Family","rdfs:label":"Shen_2019_Family_1","member":{"id":"https://genegraph.clinicalgenome.org/r/a8699e83-396b-49b1-8d4a-c91db71c8214","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30839500","rdfs:label":"Shen_2019_Patient_III-10","ageType":"AgeAtReport","ageUnit":"Years","ageValue":39,"allele":{"id":"https://genegraph.clinicalgenome.org/r/349870de-6a24-483d-bb36-ca5c7dd5bb48","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_176824.3(BBS7):c.389_390del (p.Asn130ThrfsTer4)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339158"}},"detectionMethod":"Genotyping consisted of exome sequencing, followed by Sanger sequencing of the BBS7 locus.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"The proband has been diagnosed with Bardet-Biedl syndrome.","phenotypes":["obo:HP_0000470","obo:HP_0000822","obo:HP_0000678","obo:HP_0001513","obo:HP_0000107","obo:HP_0005280","obo:HP_0000140","obo:HP_0000750","obo:HP_0001156","obo:HP_0011342","obo:HP_0010442"],"previousTesting":true,"previousTestingDescription":"Previous genotyping consisted of exome sequencing.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d3a99c1f-3a35-4a94-a902-ef20604b9993_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30839500","allele":{"id":"https://genegraph.clinicalgenome.org/r/349870de-6a24-483d-bb36-ca5c7dd5bb48"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"The affected family members have been diagnosed with Bardet-Biedl syndrome.","phenotypeNegativeAlleleNegative":5,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0005280","obo:HP_0000822","obo:HP_0000470","obo:HP_0001513","obo:HP_0000750","obo:HP_0001156","obo:HP_0000107","obo:HP_0010442","obo:HP_0011342"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a8699e83-396b-49b1-8d4a-c91db71c8214"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/98da555f-f6ea-4c20-95aa-e1a7f6925268_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98da555f-f6ea-4c20-95aa-e1a7f6925268","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25553308","rdfs:label":"Shin_2015_Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":26,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/8b963956-3c70-45ab-9225-ff3795fff4a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_176824.3(BBS7):c.728G>A (p.Cys243Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA233521"}},{"id":"https://genegraph.clinicalgenome.org/r/2405aced-aa5b-4b6e-9660-d430b4be2e32","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_176824.3(BBS7):c.103-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358045281"}}],"detectionMethod":"Genotyping was performed using Sanger sequencing of the BBS1, BBS2, BBS3, BBS4, BBS5, BBS6, BBS7, BBS8, BBS9, BBS10, BBS11, BBS12, BBS13, and BBS14 genes.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"The patient has been diagnosed with Bardet-Biedl syndrome and has poor corticomedullary differentiation in the kidneys and optic disc atrophy.","phenotypes":["obo:HP_0000580","obo:HP_0001249","obo:HP_0001640","obo:HP_0001956","obo:HP_0004719","obo:HP_0008043","obo:HP_0012584","obo:HP_0001631","obo:HP_0000648","obo:HP_0007754","obo:HP_0003774","obo:HP_0000618","obo:HP_0100598","obo:HP_0007737"],"previousTesting":true,"previousTestingDescription":"Previous genotyping consisted of Sanger sequencing of the BBS1, BBS2, BBS3, BBS4, BBS5, BBS6, BBS8, BBS9, BBS10, BBS11, BBS12, BBS13, and BBS14 genes.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/60c0458d-64fe-4e60-a4e4-7cfad5ab67d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25553308","allele":{"id":"https://genegraph.clinicalgenome.org/r/2405aced-aa5b-4b6e-9660-d430b4be2e32"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/4af263fb-6172-415d-bbdc-ab497c855f0b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25553308","allele":{"id":"https://genegraph.clinicalgenome.org/r/8b963956-3c70-45ab-9225-ff3795fff4a2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/4af263fb-6172-415d-bbdc-ab497c855f0b","type":"EvidenceLine","dc:description":"NM_018190.4:c.728G>A (p.Cys243Tyr) is a missense variant in exon 8 that does not have functional evidence of an impact on the protein product, but has been previously reported in the homozygous state in a patient affected with retinitis pigmentosa (PMID: 23847139) and another affected with Bardet-Biedl syndrome (PMID: 26325687).","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4af263fb-6172-415d-bbdc-ab497c855f0b_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/60c0458d-64fe-4e60-a4e4-7cfad5ab67d8","type":"EvidenceLine","dc:description":"NM_018190.4:c.103-1G>A is a canonical splice site variant in intron 2 adjacent to the boundary with exon 3 and does not have functional evidence of an impact on the protein product.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60c0458d-64fe-4e60-a4e4-7cfad5ab67d8_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.1},{"id":"https://genegraph.clinicalgenome.org/r/809d4174-6a8e-4838-87c4-1e32b576e1d5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/809d4174-6a8e-4838-87c4-1e32b576e1d5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12567324","rdfs:label":"Badano_2003_Family_KK26_Proband_05","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c18c97e-c164-44cf-b753-7df7c1fdf1a9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_176824.3(BBS7):c.709_712del (p.Lys237GlufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252535"}},"detectionMethod":"Genotyping first identify regions of homozygosity unique to the affected family member, then performed Sanger sequencing of the BBS7 locus.","firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"The patient has been diagnosed with Bardet-Biedl syndrome. Specific phenotypes have not been described in detail.","previousTesting":true,"previousTestingDescription":"Previous genotyping consisted of linkage mapping using a 10-cM linkage map set to identify regions of homozygosity unique to the affected family member only.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/fce301ed-ef07-4a53-a9b9-a0886dd0980f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12567324","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c18c97e-c164-44cf-b753-7df7c1fdf1a9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/fce301ed-ef07-4a53-a9b9-a0886dd0980f","type":"EvidenceLine","dc:description":"NM_176824.3(BBS7):c.709_712del (p.Lys237fs) is an out-of-frame deletion variant in exon 7 of 18 and is predicted to trigger nonsense-mediated decay or to at least truncate the C-terminal 67% of the protein product. Down-scoring has been performed to account for the known consanguinity of the family, the homozygous state of the variant, and the absence of available phenotype details.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fce301ed-ef07-4a53-a9b9-a0886dd0980f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a8699e83-396b-49b1-8d4a-c91db71c8214_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8699e83-396b-49b1-8d4a-c91db71c8214"},{"id":"https://genegraph.clinicalgenome.org/r/d3a99c1f-3a35-4a94-a902-ef20604b9993","type":"EvidenceLine","dc:description":"NM_176824.3(BBS7):c.389_390del (p.Asn130fs) is an out-of-frame deletion variant in exon 5 of 18 that is predicted to trigger nonsense-mediated decay or at least truncation of the C-terminal 82% of the protein product. Down-scoring has been performed for the homozygous state of the variant and the suspected consanguinity of the proband's family.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3a99c1f-3a35-4a94-a902-ef20604b9993_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/a09e1836-927c-424d-b10c-fd93f3e6dc6b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a09e1836-927c-424d-b10c-fd93f3e6dc6b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f1db25c-4cfd-41f2-b8f3-2152a03a6c19","type":"EvidenceLine","dc:description":"The increase in BBS7 in retinal tissues relative to other human tissues is subtle, so reduced scoring is recommended.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/644aa94f-1442-4e9b-ad8e-3df85c652431","type":"Finding","dc:description":"BBS7 mRNA is widely expressed in human tissues but reaches its highest levels of expression in retinal tissues (Figure 2). This has been confirmed independently in an RNA-seq dataset profiling human tissues (PMID:Â 30239781).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12567324","rdfs:label":"BBS7 is expressed at highest levels in retina tissues.","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/6c8e4ebc-7fb7-4008-88c8-308f010feef9","type":"EvidenceLine","dc:description":"BBS4 immunoprecipitation results in co-purification of BBS7 and 6 other proteins encoded by genes implicated in Bardet-Biedl syndrome. Higher than default scoring should be considered.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/449dd834-47df-429c-aa0f-12fd2fa25500","type":"Finding","dc:description":"Antibody-based isolation of BBS4 results in co-purification of BBS7, as well as BBS1, BBS2, BBS5, BBS8, and BBS9 in stoichiometric quantities. The co-purifying proteins are shown separated by gel electrophoresis in Figure 1F and were identified and quantified by mass spectrometry in Table S1. All 8 proteins are encoded by genes linked to Bardet-Biedl syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17574030","rdfs:label":"BBS7 interacts with other components of the BBSome.","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7ead8f35-8ba1-421d-a3ce-e6bdb748e663","type":"EvidenceLine","dc:description":"Up-scoring for this evidence has been recommended due to the high number of other BBSome components asserted to harbor variants causing the same disease entity (Bardet-Biedl syndrome).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a32cc6be-545c-4a43-bb1d-c5fbb550e131","type":"Finding","dc:description":"Other BBSome components have been asserted in connection with various monogenic forms of Bardet-Biedl syndrome, including BBS1 (PMID: 12118255), BBS2 (PMID: 11285252), ARL6 (PMID: 15258860), BBS4 (PMID: 11381270), BBS5 (PMID: 15137946), MKKS (PMID: 10973238, PMID: 10973251), and TTC8 (PMID: 14520415).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15231740","rdfs:label":"BBS7 is a BBSome protein linked to Bardet-Biedl syndrome.","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2dc66997-5cc1-4250-a8e1-45c7984c5478","type":"EvidenceLine","dc:description":"BBS7 localization is consistent with a biochemical role in ciliogenesis.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75f3eafd-838b-4c59-a01f-8648877fa603","type":"Finding","dc:description":"BBS7 localization to the membrane of the cilium matches the localization of other members of the BBSome complex (PMID: 17574030) and is consistent with a role in ciliogenesis. This may underlie the combination of polydactyly and kidney and retinal phenotypes observed in patients harboring BBS7 variants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15231740","rdfs:label":"BBS7 regulates cilium assembly.","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a09e1836-927c-424d-b10c-fd93f3e6dc6b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa20350f-ac29-4f66-b8e1-5bf38c16b4f5","type":"EvidenceLine","dc:description":"This model provides insights into the human disease state at the cellular level, but the model animals are unable to recapitulate the organ-level dysfunction of affected patients.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b1738d8-3d87-4bb6-a34b-649fbd91ab27","type":"Finding","dc:description":"This is a naturally occurring C. elegans model of biallelic bbs-7 disruption. The mutant animals exhibit reduced chemotaxis (dependent on two chemosensory neurons, Figure 2E), shorter cilia (Figure 3), defective localization of IFT particles (Figure 4), and reduced intraflagellar transport (Figure 5). Rescue of chemotaxis with expression of the wild-type C. elegans bbs-7 gene directly linked the defect with bbs-7 (Figure 2E). This model is consistent with the human disease at the cellular level, but does not recapitulate the organ-level dysfunction of affected patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15231740","rdfs:label":"Naturally occurring bbs-7 loss-of-function C. elegans model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/580c368c-bfad-4841-8c7c-124d94436d18","type":"EvidenceLine","dc:description":"Up-scoring from the default score has been considere for the high degree of phenotype match. The only human patient phenotypes missing from the affected model animals are polydactyly and cardiac abnormalities, which were absent, and obesity, which was only mildly observed in one of three cases.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b4742dc-b5d6-4e93-a368-868cdb7115e6","type":"Finding","dc:description":"This is a naturally occurring Rhesus macaque model of biallelic BBS7 disruption. The mutant animals exhibit hypoechoic kidney lesions (Figure 1), retinal atrophy with lack of retinal vasculature (Figure 3A), RPE atrophy (Figure 3B), severe atrophy of retinal layers by OCT with greater severity centrally (Figure 3C), retinal gliosis (Figure 3D), Severely reduced amplitudes and delayed time courses of both dark-adapted and light-adapted flicker ERG (Figure 4), reduced brain volume (Figure 5B), dilation of the lateral ventricle (Figure 5A), cystic kidney tubules with loss of nephrons replaced with fibrosis, tubule atrophy, and ectasia (Figure 7), reduced size and histological maturity of testes (Table 1), and vision deficits (Table 1).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31589838","rdfs:label":"Naturally occurring BBS7 loss-of-function primate model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5967d5a4-3e63-4ba2-8843-ec02d10b5926","type":"EvidenceLine","dc:description":"The affected mice recapitulate many of the phenotypes of the affected patients, other than polydactyly and abnormalities of the heart or kidneys.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16135bb1-bb7a-4324-947b-57bfb8be4270","type":"Finding","dc:description":"This is a genetically engineered mouse model of biallelic Bbs7 disruption. The mutant animals with biallelic Bbs7 disrupion exhibit photoreceptor inner and outer segment loss (Figure 1), ventriculomegaly (Figure 1), reduced number of cilia and shortened cilia in brain tissue (Figure 2), abnormal axonemal structure / microtubule number abnormality in brain cilia (Figures 2F, 2G), lack of sperm flagella (Figure 3), Abnormal sperm axoneme microtubule organization (Figure 3), destabilization /absence of BBS2 in testes (Figure 4), and abnormal accumulation of some ciliary membrane proteins (dopamine D1 receptor, Figure 6) but not others (polycystin-1 or polycystin-2, Figure 5).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23572516","rdfs:label":"Genetically engineered Bbs7 homozygous knockout mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":9633,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/l5L_Ps9JXJw","type":"GeneValidityProposition","disease":"obo:MONDO_1040042","gene":"hgnc:18758","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a09e1836-927c-424d-b10c-fd93f3e6dc6b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}